FDA recall record

Teva ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) recall — FDA D-1494-2016

CGMP Deviations

Class IIclassification
D-1494-2016official record ID
Sep 14, 2016report date

Recall record at a glance

Official recordD-1494-2016
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmTeva North America
Report dateSep 14, 2016
Recall initiation dateJun 17, 2016
Quantity1,299 bags
LocationHorsham, PA, United States

Official product description

ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton).

Why the product was recalled

CGMP Deviations

Distribution information

Nationwide and Puerto Rico

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.